Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis

BACKGROUND: Amyloid transthyretin (ATTR) amyloidosis is caused by the systemic deposition of transthyretin molecules, either normal (wild‐type ATTR, ATTRwt) or mutated (variant ATTR, ATTRv). ATTR amyloidosis is a disease with a severe impact on patients’ quality of life (QoL). Nonetheless, limited a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aimo, Alberto, Rapezzi, Claudio, Perfetto, Federico, Cappelli, Francesco, Palladini, Giovanni, Obici, Laura, Merlini, Giampaolo, Di Bella, Gianluca, Serenelli, Matteo, Zampieri, Mattia, Milani, Paolo, Licordari, Roberto, Teresi, Lucio, Ribarich, Nicolò, Castiglione, Vincenzo, Quattrone, Filippo, De Rosis, Sabina, Vergaro, Giuseppe, Panichella, Giorgia, Emdin, Michele, Passino, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596396/
https://www.ncbi.nlm.nih.gov/pubmed/33982288
http://dx.doi.org/10.1111/eci.13598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596396/
https://www.ncbi.nlm.nih.gov/pubmed/33982288
http://dx.doi.org/10.1111/eci.13598

Ejemplares similares